Show simple item record

dc.contributor.authorCastro-Vega, Luis Jaime
dc.contributor.authorCalsina, Bruna 
dc.contributor.authorBurnichon, Nelly
dc.contributor.authorDrossart, Tom
dc.contributor.authorMartínez-Montes, Ángel M
dc.contributor.authorVerkarre, Virginie
dc.contributor.authorAmar, Laurence
dc.contributor.authorBertherat, Jérôme
dc.contributor.authorRodríguez-Antona, Cristina
dc.contributor.authorFavier, Judith
dc.contributor.authorRobledo, Mercedes
dc.contributor.authorGimenez-Roqueplo, Anne-Paule
dc.date.accessioned2021-03-23T10:08:10Z
dc.date.available2021-03-23T10:08:10Z
dc.date.issued2020-12-10
dc.identifier.citationClin Transl Med . 2020;10(8):e260.es_ES
dc.identifier.issn2001-1326es_ES
dc.identifier.urihttp://hdl.handle.net/20.500.12105/12397
dc.description.sponsorshipThis study was funded by European Union Seventh Framework Program (FP7/2007-2013) under grant agreement (grant number: 259735), Horizon 2020 (grant number: 633983), Institut National du Cancer and Direction Generale de l'Offre de Soins (DGOS), Programme de Recherche Translationnelle en cancerologie (PRT-K 2014, COMETE-TACTIC, INCa_DGOS_8663), the Plan Cancer: Appel a projets Epigenetique et Cancer 2013 (EPIG201303 METABEPIC), Agence Nationale de la Recherche (ANR-2011-JCJC-00701 MODEOMAPP), Instituto de Salud Carlos III (ISCIII), Accion Estrategica en Salud, cofounded by FEDER (PI14/00240 and PI17/01796) and the Paradifference Foundation. Bruna Calsina was supported by Rafael del Pino Foundation (Becas de ExcelenciaRafael del Pino 2017) and currently by ISCIII project PI17/01796. We thank all members of the Genetics Department, Biological Resources Center and Tumor Bank Platform, Hopital europeeen Georges Pompidou (BB-0033-00063) for technical support.es_ES
dc.language.isoenges_ES
dc.publisherJOHN WILEY & SONS LTDes_ES
dc.relation.isversionofPublisher's versiones_ES
dc.rights.urihttp://creativecommons.org/licenses/by-nc-sa/4.0/*
dc.subjectPARAGANGLIOMASes_ES
dc.titleOverexpression of miR-483-5p is confined to metastases and linked to high circulating levels in patients with metastatic pheochromocytoma/paraganglioma.es_ES
dc.typeArtículoes_ES
dc.rights.licenseAtribución-NoComercial-CompartirIgual 4.0 Internacional*
dc.identifier.pubmedID33377638es_ES
dc.format.volume10es_ES
dc.format.number8es_ES
dc.format.pagee260es_ES
dc.identifier.doi10.1002/ctm2.260es_ES
dc.contributor.funderEuropean Commissiones_ES
dc.contributor.funderFrench National Research Agency (ANR)es_ES
dc.contributor.funderInstituto de Salud Carlos III - ISCIIIes_ES
dc.contributor.funderRafael del Pino Foundationes_ES
dc.contributor.funderParadifference Foundationes_ES
dc.description.peerreviewedes_ES
dc.relation.publisherversionhttps://doi.org/ 10.1002/ctm2.260.es_ES
dc.identifier.journalClinical and translational medicinees_ES
dc.repisalud.institucionCNIOes_ES
dc.repisalud.orgCNIOCNIO::Grupos de investigación::Grupo de Cáncer Endocrino Hereditarioes_ES
dc.relation.projectIDinfo:eu-repo/grantAgreement/ES/PI17/01796es_ES
dc.relation.projectIDinfo:eu-repo/grantAgreement/ES/PI14/00240es_ES
dc.rights.accessRightsinfo:eu-repo/semantics/openAccesses_ES


Files in this item

Acceso Abierto
Thumbnail
Acceso Abierto

This item appears in the following Collection(s)

Show simple item record

Atribución-NoComercial-CompartirIgual 4.0 Internacional
This item is licensed under a: Atribución-NoComercial-CompartirIgual 4.0 Internacional